FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
FDA to review removal of Eli Lilly weight loss drug from shortage list
The U.S. Food and Drug Administration (FDA) has agreed to reconsider its decision to remove tirzepatide, the active ...
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...
ConsumerAffairs10d
Mountjaro, Zepbound removed from FDA's shortage list
The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...
BioPharma Dive14d
FDA, after delay, clears Regeneron and Sanofi drug for COPD
The Food and Drug Administration on Friday ... European regulators approved Dupixent for COPD in July, but Regeneron and Sanofi have had to wait longer in the U.S., where the FDA requested additional ...
Outlookindia15d
FDA Approves First New Schizophrenia Drug In 30 Years: Cobenfy Offers Hope With Fewer Side Effects | Details
For the first time in nearly three decades, a new treatment for schizophrenia has been approved by the U.S. Food and Drug Administration (FDA). On September 26, the FDA gave the green light to ...
Onlymyhealth16d
Top-Rated Keto Supplements: The 5 Most Effective Weight Loss Pills for a Keto Diet
Designed to support adherence to the ketogenic diet and maximize its benefits, keto weight loss pills offer additional support for those facing difficulties or seeking enhanced results.
USA Today16d
This FDA-approved drug promises a new way to treat schizophrenia
People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...
Yahoo Finance16d
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
September 27, 2024--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of Flyrcado™ (flurpiridaz F 18 ...
Time16d
FDA Approves the First New Schizophrenia Drug in Decades
No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric ...
Newsweek16d
FDA Approves New Schizophrenia Drug in 70-Year First
The U.S. Food and Drug Administration has approved a new drug for schizophrenia ... which is one of the 15 leading causes of disability worldwide, the FDA reports. Individuals with this disease ...
kffhealthnews16d
Antipsychotic Drug Cobenfy Wins FDA Approval For Schizophrenia Treatment
Meanwhile, thousands of patients allege in a lawsuit that drugs used for diabetes and weight loss have caused other health problems. The Washington Post: FDA Approves New Type Of Antipsychotic Drug, A ...